Diagnos Laboratorium Utama Tbk. vs Sarana Menara Nusantara Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 22.7K 24h volume), while Sarana Menara Nusantara Tbk. trades at Rp378 (market cap 22.34T, 9.28M 24h volume). The key difference: Sarana Menara Nusantara Tbk. is far larger — about 72.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Sarana Menara Nusantara Tbk. is more actively traded (9.28M versus 22.7K). Which is the better fit depends on your goals.
| DGNS | TOWR | |
|---|---|---|
Market Cap | 308B | 22.34T |
Volume | 22.7K | 9.28M |
Lot | 227 | 92.81K |
Turnover | 5.17M | 3.5B |
Average Price | 227.59 | 376.68 |
Value | 5.17M | 3.5B |
Indicative Equilibrium Price | 230 | 376 |
Indicative Equilibrium Volume | 110 | 43.99K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Sarana Menara Nusantara Tbk (the company) was established based on Deed of Establishment (Article of Association) No.31 dated June 2, 2008 drawn up in the presence of Dr. Irawan Soerodjo, S.H., MSi., Notary in Jakarta.The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Irawan Soerodjo, S.H., dated Nov 18, 2009, concerning among others, the change in par value, and public offering
Read more on TOWR →